Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT04932655 Completed - Healthy Volunteers Clinical Trials

Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers

Start date: May 4, 2021
Phase: Phase 1
Study type: Interventional

This study will compare the pharmacokinetics of the Phase 3 simufilam 100 mg oral tablet when taken fasted versus following a high-fat or low-fat meal. Additionally, the Phase 3 oral tablet will be compared to the Phase 2 oral tablet for bioequivalence under fasted conditions.

NCT ID: NCT04932005 Completed - Healthy Volunteers Clinical Trials

A Study of DZD2269 in Healthy Adult Participants

Start date: June 29, 2021
Phase: Phase 1
Study type: Interventional

This is a research study in healthy participants. The purpose of this study is to see how safe the study drug is and how well it is tolerated after dosing. This study will also investigate pharmacokinetics of DZD2269; renal excretion of DZD2269 will also be evaluated. The study will also measure biomarkers such as pCREB in the blood.

NCT ID: NCT04924140 Completed - Healthy Volunteers Clinical Trials

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

Start date: June 30, 2021
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the absolute bioavailability of a single, fixed subcutaneous (SC) dose of aducanumab compared with a single weight-based intravenous (IV) dose of aducanumab in healthy volunteers. The secondary objectives of this study are to assess the safety and tolerability of aducanumab administered SC in healthy volunteers and to characterize additional pharmacokinetic (PK) parameters of a single, fixed SC dose of aducanumab and a weight-based IV dose of aducanumab in healthy volunteers.

NCT ID: NCT04920903 Completed - Healthy Volunteers Clinical Trials

A Single and Multiple Ascending Dose Study of COR588

Start date: August 26, 2021
Phase: Phase 1
Study type: Interventional

The study is a randomized, double-blind, placebo-controlled, single and multiple ascending dose study to assess the safety and tolerability of COR588 HCl in healthy male and female subjects.

NCT ID: NCT04919954 Completed - Diabetes Clinical Trials

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Start date: July 1, 2021
Phase: Phase 1
Study type: Interventional

This study will determine the tissue penetration of a broad-spectrum orally bioavailable carbapenem, tebipenem pivoxil hydrobromide (SPR994) (Spero Therapeutics, Inc.), into the extracellular, interstitial fluid of soft tissue in diabetic patients with lower limb wound infections. Penetration will be compared with a group of healthy volunteer control participants.

NCT ID: NCT04916431 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults

Start date: July 28, 2021
Phase: Phase 1
Study type: Interventional

There are 2 parts to this study: a single ascending dose (single dose of mRNA-6231) part and a multiple ascending dose (repeat doses of mRNA-6231) part. The main goal of this study is to evaluate the safety and tolerability of escalating doses of single and repeat subcutaneous (SC) administration of mRNA-6231. Dose levels of mRNA-6231 are planned to be investigated in a dose-escalation manner.

NCT ID: NCT04910061 Completed - Healthy Volunteers Clinical Trials

Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

Start date: August 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the safety, pharmacokinetic profile, and effects of nicotinamide mononucleotide (NMN-C) in healthy adults, 18-65 years of age. The effects will be studied over the course of 30 days in a repeated-dose study through the collection of blood and urine samples, and administration of surveys and questionnaires.

NCT ID: NCT04909242 Completed - Healthy Volunteers Clinical Trials

Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants

Start date: April 21, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomised, double-blind, placebo-controlled, single ascending dose sequential group study in healthy participants. This study consists of three parts: Part A (single dose escalation, SAD) , Part B (food effect, FE) and Part C (relative bioavailability, BA).

NCT ID: NCT04905342 Completed - Healthy Volunteers Clinical Trials

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers

BE
Start date: August 14, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the pharmacokinetics of NVP-1805 and coadministration of NVP-1805-R1 with NVP-1805-R2.

NCT ID: NCT04905043 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants

Start date: June 3, 2016
Phase: Phase 1
Study type: Interventional

This study will evaluate the effect of gastric pH on acalabrutinib pharmacokinetics in healthy participants.